Boric acid for yeast infection is a second-line option, not a first step. It has the best evidence for recurrent infections and for non-albicans species such as Candida glabrata, where the CDC lists 600 mg vaginally once daily for 3 weeks[1]. Across 27 studies of yeast infections, boric acid cured about 76% of cases on average[2].
For BV, the evidence is thinner. The CDC describes boric acid only as a possible add-on after antibiotics for repeated recurrences, based on limited data[3]. Boric acid is not an FDA-approved drug, and safety data are sparse[4]. This guide covers what the trials found, the regimens studied, side effects, and who should not use it.
Get medical help promptly if this is your first episode of symptoms, you are not sure what is causing them, symptoms worsen or persist after over-the-counter treatment, or you may have been exposed to an STI[5]. If you are pregnant, see a clinician rather than self-treating: BV in pregnancy is linked to preterm birth, and boric acid should be avoided[3][4].
Does boric acid work for yeast infections?
Yes, in studies. Its clearest benefit is for infections that standard azole antifungals do not clear. For an ordinary first yeast infection, azoles remain the treatment of choice and relieve symptoms with negative cultures in 80% to 90% of people who finish treatment[1][6]. Our guide to Candida overgrowth and yeast infections covers those standard options.
The trials are small and mostly old. Of 41 studies in the 2024 systematic review, only four were randomized trials[2]:
| Study | Who | Regimen | Result |
|---|---|---|---|
| Double-blind trial, 1981 | Women with C. albicans infection | 600 mg capsule nightly for 14 days vs. nystatin | 92% vs. 64% cured at 7 to 10 days; 72% vs. 50% at 30 days[7] |
| Randomized trial, 2007 (n=112) | Women with diabetes; 61.3% had C. glabrata | 600 mg daily for 14 days vs. one 150 mg fluconazole dose | C. glabrata cure 63.6% vs. 28.6%[8] |
| Chart review, 2003 (n=141) | Women with C. glabrata | 600 mg daily for 2 to 3 weeks | Success in 64% and 71% at two clinics; no gain from 21 vs. 14 days[9] |
| Systematic review, 2011 (14 studies) | Recurrent yeast infections | Various | Mycologic cure 40% to 100%; no difference in recurrence rates[10] |
That last point matters: boric acid can clear an episode, but the 2011 review found no study showing it lowers the chance of the next one[10].
Why it matters for Candida glabrata
Most yeast infections are caused by Candida albicans[5]. In recurrent yeast infections, defined as three or more episodes in under a year, Candida glabrata and other non-albicans species turn up in 10% to 20% of women[1].
These species respond poorly to azoles, and fluconazole-resistant Candida albicans is a growing problem, leaving few alternatives[11]. In the 2007 trial, the advantage of boric acid over fluconazole was specific to Candida glabrata; cure rates for Candida albicans did not differ significantly between the two[8].
Does boric acid help BV?
Possibly, as an add-on, but no large randomized trial has tested it. In 2015, researchers launching the first randomized trial of boric acid against metronidazole noted that no clinical trial of boric acid for BV existed yet[12]. Standard treatment is still an antibiotic, as described on our bacterial vaginosis page[3].
What the BV evidence shows:
CDC option for multiple recurrences: an oral nitroimidazole for 7 days, then 600 mg vaginal boric acid daily for 21 days, then metronidazole gel twice weekly for 4 to 6 months. The CDC calls the supporting data limited[3].
The study behind that regimen: a chart review of 58 women, with no comparison group. Cure was 87% at 12 weeks, falling to 65% at 28 weeks, and half had relapsed by 36 weeks[13].
Boric acid alone after failed antibiotics: in 52 women with recurrent BV, 14 days of 600 mg brought 88.5% to a normal Nugent score by day 30. The authors note that a single-arm design cannot prove efficacy[14].
An investigational boric acid product: in a phase 2 trial, TOL-463, a boric acid-based insert, achieved clinical cure in 59% of women with BV[15]. It is not the same as over-the-counter boric acid.
How is recurrent BV treated?
Recurrent BV affects 15% to 30% of women with BV, and recurrence exceeds 60% after standard therapy[14]. The CDC first suggests retreating with the same or a different antibiotic, or twice-weekly metronidazole gel for more than 3 months, which reduces recurrences only while it is used[3]. Boric acid enters the picture after those. For the role of live bacteria, see our guide to probiotics for BV and yeast infections.
How does boric acid kill yeast and bacteria?
Nobody knows exactly, and it is not simply by lowering pH. In the 1981 trial, lab tests found boric acid fungistatic, meaning it stops yeast from growing, with an effect unrelated to pH[7]. That fits the fact that yeast infections usually occur at a normal vaginal pH below 4.5[1].
A 2024 systematic review describes broad effects on microbes rather than one drug target:
- inhibition of NAD-dependent enzymes in yeast mitochondria;
- inhibition of hyphal (thread-like) growth in yeast;
- reduced biofilm production by bacteria and fungi in lab studies[2].
Broad action may make resistance less likely to develop than with antifungals[2].
The microbiome angle. BV is linked to a vaginal biofilm that helps bacterial pathogens survive treatment, and researchers added boric acid to BV regimens specifically to remove it[13]. Our Gardnerella vaginalis page covers the best-known BV species and its biofilm. In the 2025 study, clue cells, a microscope marker of BV, fell from 68.4% to 8.3% of women after treatment[14]. Whether protective species such as Lactobacillus crispatus recover afterward has not been measured in the studies we read.
The safety review also notes that the standard 600 mg dose is "largely arbitrary": no dose-finding studies have been done[4].
How are boric acid suppositories used in studies?
Studies use a 600 mg capsule inserted into the vagina, never swallowed, with a course length that depends on the condition[2]. These are the regimens studies and guidelines used; they are not a self-treatment plan.
| Use | Regimen studied | Source |
|---|---|---|
| Non-albicans yeast infection that recurs after a 7 to 14 day azole course | 600 mg daily for 3 weeks | CDC[1] |
| Recurrent yeast infection | 600 mg daily for 2 weeks | 2024 systematic review[2] |
| Recurrent BV, after 7 days of oral antibiotic | 600 mg daily for 21 days, then metronidazole gel maintenance | CDC[3] |
| Maintenance for recurrent yeast or BV | 300 or 600 mg two to three times a week; average use 13 months | Clinic chart review[16] |
| Trichomoniasis resistant to standard drugs | Case reports only, up to 600 mg twice daily for 1 to 5 months | Systematic review[17] |
Course length matters. In a survey of 206 patients at a US vulvovaginal clinic, half had used boric acid, but only 2.9% had used it for longer than 21 days, the duration the CDC describes[18].
What not to do after inserting boric acid
These precautions come from guideline advice summarized in the 2021 safety review[4]:
- Do not take it by mouth; insert it vaginally only.
- Do not store it near oral medicines or within reach of children.
- Do not use it without reliable contraception, given the pregnancy concerns below.
- Do not push through irritation; UK guidance allows dropping to 300 mg daily, so ask your prescriber.
- Do not keep repeating short courses for returning symptoms; get a diagnosis instead.
Boric acid side effects
Side effects in studies are usually mild and local. The 2024 systematic review counted adverse events in 7.3% of treated women, typically mild and temporary[2]. Reported effects include:
- Vaginal burning: in fewer than 10% of cases across the 2011 review[10].
- Watery discharge while the capsule dissolves[10].
- Redness of the vaginal tissue[10].
- Irritation or leakage in long-term users; one woman reduced from 600 to 300 mg with good results[16].
In the 2025 BV study, 7.8% had mild adverse events and everyone finished the course[14]. ### Is it normal to experience bleeding after boric acid?
Bleeding was not among the effects reported in the reviews and studies we read[10][2]. New bleeding, pain or worsening symptoms during treatment are reasons to stop and see a clinician.
Is boric acid safe for vaginal use?
For non-pregnant adults with normal kidney function, a 2021 safety review concluded it is likely safe at the doses clinicians commonly prescribe[4]. The authors found no published report of serious toxicity from vaginal use since the 1880s. That case involved packing roughly 25 to 100 times today's dose into the vagina[4]. Little reaches the bloodstream: one volunteer absorbed an estimated 6%, and boron levels were undetectable 48 hours after use[4].
The same reviewers still advise that boric acid be prescribed by a clinician rather than bought and used unsupervised. Products vary in dose and purity, and self-treatment can mask an infection that needs other care[4].
Swallowing is the real danger
Boric acid taken by mouth is almost fully absorbed[4]. Ingestions cause nausea, vomiting, abdominal pain and diarrhea, and severe cases have caused a red peeling rash, drowsiness and kidney failure. Potentially lethal adult doses are cited as 15 to 20 g, though no clear threshold has been established[4]. Keep capsules away from children.
Pregnancy and breastfeeding
Do not use boric acid if you are pregnant or could be. In one case-control study, exposure in months 2 to 3 of pregnancy was linked to a 2.8-fold higher risk of birth defects[4].
That study had methodological flaws, but high oral doses cause birth defects in animals, so guidelines advise avoidance[4]. For yeast infections in pregnancy, the CDC recommends 7 days of a topical azole[1]. The safety review did not assess breastfeeding, so ask your clinician before using boric acid while nursing.
Do gynecologists recommend boric acid?
Many do, for specific situations.
A 2024 review in Obstetrics & Gynecology advises that, for recurrent yeast infections or BV, the first step is a longer course of a first-line drug. When that fails, vaginal boric acid is "likely the cheapest and easiest alternative option"[19]. Experts reviewing the 2021 CDC guidelines concluded boric acid "appears useful" for symptomatic non-albicans yeast infections[6]. An earlier systematic review supported it for recurrent infections resistant to conventional therapy[20].
What clinicians do not endorse is routine use for odor or "pH balance." Surveys of buyers show boric acid is more often bought for prevention, especially of odor and BV, than for treatment[21]. Clinic researchers described this use as almost always for unsupported reasons[18]. For what different smells usually mean, see our vaginal odor guide.
When to see a doctor
See a clinician before or instead of using boric acid if[5][19]:
- this is your first episode of yeast-like symptoms, or you are unsure of the cause;
- symptoms do not improve after over-the-counter treatment, get worse, or come back;
- you develop new symptoms or may have been exposed to an STI;
- you are pregnant or trying to conceive;
- you have had three or more episodes in a year, which calls for testing to identify the species.
When treatment fails, clinicians reconsider the diagnosis. Desquamative inflammatory vaginitis, genitourinary syndrome of menopause and vulvodynia can all mimic infection[19].
This article is for general educational purposes and is not medical advice. Boric acid is not FDA-approved, and most of the evidence comes from small or uncontrolled studies. Talk to a qualified healthcare professional before using boric acid, particularly if you are pregnant or could become pregnant, are breastfeeding, have kidney disease, are immunocompromised, taking prescription medication, or managing a diagnosed condition.
Frequently Asked Questions
How long do you leave in a boric acid suppository?
You do not remove it. The gelatin capsule is inserted into the vagina and dissolves there, which is why a watery discharge during treatment is a commonly reported effect. In a chart review of 78 women on long-term boric acid, one reported the dissolved product leaking out the next day. Studies and the CDC regimen use one 600 mg capsule once daily for the full course, not a single overnight dose.
Is 3 days of boric acid enough for BV?
Three days is shorter than any regimen in the studies we read. The CDC option for recurrent BV uses 600 mg daily for 21 days after a 7-day course of an oral antibiotic, and a 2025 study of recurrent BV used 14 days. A survey at a US vulvovaginal clinic found only 2.9% of boric acid users had used it for more than 21 days, the length the CDC describes. If symptoms return after short courses, get tested rather than repeating them.
Can boric acid remove a fishy smell?
In one retrospective study of 52 women with recurrent BV, vaginal odor fell from 92.3% to 1.9% after 14 days of 600 mg boric acid. That study had no comparison group. A fishy odor is a classic sign of BV, which usually needs antibiotics first, so masking the smell with boric acid can delay the right diagnosis. Surveys show many buyers use boric acid mainly for odor and prevention, a use no guideline supports.
Is boric acid better than Monistat or fluconazole?
Not for a typical yeast infection. Azole antifungals such as miconazole (Monistat) and fluconazole remain the treatment of choice for uncomplicated yeast infections, with symptom relief and negative cultures in 80% to 90% of people who finish treatment. Boric acid has an advantage in a narrower group: in a trial of women with diabetes infected with Candida glabrata, 63.6% were cured with 14 days of boric acid versus 28.6% with one fluconazole dose.
How long does boric acid take to work?
Studies measure cure at the end of a full course rather than after a few nights. In the original 1981 trial, symptoms eased at a similar speed to nystatin, and 92% of women were cured 7 to 10 days after finishing 14 nightly capsules. For recurrent BV, one study assessed results at day 30, after a 14-day course. If symptoms have not improved by the end of the course, see a clinician.
What should I do if I swallowed a boric acid suppository?
Contact poison control or emergency services right away, even if you feel fine. Swallowed boric acid is almost completely absorbed. In reported ingestions, nausea, vomiting, abdominal pain and diarrhea were common, and severe cases involved skin rash, drowsiness and kidney failure. Most reported ingestions caused no symptoms, but no safe threshold has been established. US obstetric guidance warns that boric acid can be fatal if swallowed.
Can I have sex while using boric acid?
The studies we read did not test sex during treatment, so its safety for a partner is not established. ACOG guidance, as summarized in a 2021 safety review, advises reliable contraception while using boric acid because of the uncertain pregnancy risk. Routine treatment of male partners does not reduce BV recurrence, according to the CDC.
References
- Centers for Disease Control and Prevention. Vulvovaginal Candidiasis - STI Treatment Guidelines, 2021. CDC. 2021. Available at: https://www.cdc.gov/std/treatment-guidelines/candidiasis.htm ↩
- Lærkeholm Müller M, Damsted Petersen C, Saunte DML. Boric Acid for the Treatment of Vaginitis: New Possibilities Using an Old Anti-Infective Agent: A Systematic Review. Dermatologic Therapy. 2024;2024(1):2807070. doi:10.1155/2024/2807070 ↩
- Centers for Disease Control and Prevention. Bacterial Vaginosis - STI Treatment Guidelines, 2021. CDC. 2021. Available at: https://www.cdc.gov/std/treatment-guidelines/bv.htm ↩
- Mittelstaedt R, Kretz A, Levine M, et al.. Data on Safety of Intravaginal Boric Acid Use in Pregnant and Nonpregnant Women: A Narrative Review. Sexually Transmitted Diseases. 2021;48(12):e241-e247. doi:10.1097/OLQ.0000000000001562 ↩
- MedlinePlus, US National Library of Medicine. Vaginal yeast infection. MedlinePlus Medical Encyclopedia. 2026. Available at: https://medlineplus.gov/ency/article/001511.htm ↩
- Nyirjesy P, Brookhart C, Lazenby G, Schwebke J, Sobel JD. Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. Clinical Infectious Diseases. 2022;74(Suppl 2):S162-S168. doi:10.1093/cid/ciab1057 ↩
- Keller Van Slyke K, Michel VP, Rein MF. Treatment of vulvovaginal candidiasis with boric acid powder. American Journal of Obstetrics and Gynecology. 1981;141(2):145-148. doi:10.1016/s0002-9378(16)32581-9 ↩
- Ray D, Goswami R, Banerjee U, et al.. Prevalence of Candida glabrata and Its Response to Boric Acid Vaginal Suppositories in Comparison With Oral Fluconazole in Patients With Diabetes and Vulvovaginal Candidiasis. Diabetes Care. 2007;30(2):312-317. doi:10.2337/dc06-1469 ↩
- Sobel JD, Chaim W, Nagappan V, Leaman D. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. American Journal of Obstetrics and Gynecology. 2003;189(5):1297-1300. doi:10.1067/s0002-9378(03)00726-9 ↩
- Iavazzo C, Gkegkes ID, Zarkada IM, Falagas ME. Boric Acid for Recurrent Vulvovaginal Candidiasis: The Clinical Evidence. Journal of Women's Health. 2011;20(8):1245-1255. doi:10.1089/jwh.2010.2708 ↩
- Sobel JD, Sobel R. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species. Expert Opinion on Pharmacotherapy. 2018;19(9):971-977. doi:10.1080/14656566.2018.1476490 ↩
- Zeron Mullins M, Trouton KM. BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial. Trials. 2015;16(1):315. doi:10.1186/s13063-015-0852-5 ↩
- Reichman O, Akins R, Sobel JD. Boric Acid Addition to Suppressive Antimicrobial Therapy for Recurrent Bacterial Vaginosis. Sexually Transmitted Diseases. 2009;36(11):732-734. doi:10.1097/OLQ.0b013e3181b08456 ↩
- Caliskan M, Karadeniz O, Goksu M, Cetin A. Intravaginal boric acid treatment for recurrent bacterial vaginosis: short-term effects on vaginal health parameters and patient satisfaction. BMC Women's Health. 2025;25(1):536. doi:10.1186/s12905-025-04084-5 ↩
- Marrazzo JM, Dombrowski JC, Wierzbicki MR, et al.. Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial. Clinical Infectious Diseases. 2018;68(5):803-809. doi:10.1093/cid/ciy554 ↩
- Powell A, Ghanem KG, Rogers L, et al.. Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis. Sexually Transmitted Diseases. 2019;46(12):810-812. doi:10.1097/OLQ.0000000000001063 ↩
- Thorley N, Ross J. Intravaginal boric acid: is it an alternative therapeutic option for vaginal trichomoniasis?. Sexually Transmitted Infections. 2017;94(8):574-577. doi:10.1136/sextrans-2017-053343 ↩
- Dambly JM, Dutra KJ, Sobel R, et al.. Patterns of Intravaginal Boric Acid and Probiotics Use Among Patients With Chronic Vulvovaginal Symptoms. Journal of Lower Genital Tract Disease. 2025;30(1):71-75. doi:10.1097/LGT.0000000000000924 ↩
- Mitchell CM. Assessment and Treatment of Vaginitis. Obstetrics & Gynecology. 2024;144(6):765-781. doi:10.1097/AOG.0000000000005673 ↩
- Van Kessel K, Assefi N, Marrazzo J, Eckert L. Common Complementary and Alternative Therapies for Yeast Vaginitis and Bacterial Vaginosis: A Systematic Review. Obstetrical & Gynecological Survey. 2003;58(5):351-358. doi:10.1097/01.OGX.0000068791.04785.8D ↩
- Stockdale CK, Bartolo-Costello AA, Vieira-Baptista P. What Are Consumers Looking for With Boric Acid?. Journal of Lower Genital Tract Disease. 2025;29(1):93-95. doi:10.1097/LGT.0000000000000855 ↩